Gustavo Ramos Teixeira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gustavo Ramos Teixeira has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Rui Luis Reis
University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine
5 shared publications Iara Santana
Department of Pathology, R. Antenor Duarte Viléla, 1331 - Dr. Paulo Prata, Barretos, São Paulo, 14784-400, Brazil
3 shared publications- Augusto Elias Mamere
Hospital de Câncer de Barretos, Brazil
2 shared publications - Carlos Afonso Clara
Department of Neurosurgery, Barretos Cancer Hospital, Barretos, São Paulo, Brazil
2 shared publications - Esther Cecin Mamere
Universidade Federal do Rio Grande do Norte, Brazil
2 shared publications Flávia Escremim de Paula
Barretos Cancer Hospital Molecular Diagnostic Laboratory Barretos
2 shared publications
Latest Publications
- 11 April 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (9) , 104680
Improving gynecological pathology access with the OpenFlexure Microscope
- 11 April 2026
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (9) , 104680
Improving gynecological pathology access with the OpenFlexure Microscope
- Open Access
- 4 March 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 56, 101429
Clinical and molecular characterization of a large Brazilian lung cancer cohort: a real-world observational study
- 4 March 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 56, 101429
Open AccessClinical and molecular characterization of a large Brazilian lung cancer cohort: a real-world observational study
- Open Access
- 2 March 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 57, 101422
Precision diagnosis and therapy for pediatric central nervous system tumors: consensus from the Brazilian Society of Pediatric Oncology (SOBOPE)
- 2 March 2026
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 57, 101422
Open AccessPrecision diagnosis and therapy for pediatric central nervous system tumors: consensus from the Brazilian Society of Pediatric Oncology (SOBOPE)
- Open Access
- 29 June 2024
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 29 (10) , e1419-e1424
Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies
Lung cancer in never-smoker (LCINS) patients accounts for 20% of lung cancer cases, and its biology remains poorly understood, particularly in genetically admixed populations. We elucidated the molecular profile of driver genes in Brazilian LCINS. The mutational and gene fusion status of 119 lung adenocarcinomas from self-reported never-smoker patients, was assessed using targeted sequencing (NGS), nCounter, and immunohistochemistry. A panel of 46 ancestry-informative markers determined patients’ genetic ancestry. The most frequently mutated gene was EGFR (49.6%), followed by TP53 (39.5%), ALK (12.6%), ERBB2 (7.6%), KRAS (5.9%), PIK3CA (1.7%), and less than 1% alterations in RET, NTRK1, MET∆ex14, PDGFRA, and BRAF. Except for TP53 and PIK3CA, all other alterations were mutually exclusive. Genetic ancestry analysis revealed a predominance of European (71.1%), and a higher African ancestry was associated with TP53 mutations. Brazilian LCINS exhibited a similar molecular profile to other populations, except the increased ALK and TP53 alterations. Importantly, 73% of these patients have actionable alterations that are suitable for targeted treatments.
- 29 June 2024
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 29 (10) , e1419-e1424
Open AccessMolecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies
Lung cancer in never-smoker (LCINS) patients accounts for 20% of lung cancer cases, and its biology remains poorly understood, particularly in genetically admixed populations. We elucidated the molecular profile of driver genes in Brazilian LCINS. The mutational and gene fusion status of 119 lung adenocarcinomas from self-reported never-smoker patients, was assessed using targeted sequencing (NGS), nCounter, and immunohistochemistry. A panel of 46 ancestry-informative markers determined patients’ genetic ancestry. The most frequently mutated gene was EGFR (49.6%), followed by TP53 (39.5%), ALK (12.6%), ERBB2 (7.6%), KRAS (5.9%), PIK3CA (1.7%), and less than 1% alterations in RET, NTRK1, MET∆ex14, PDGFRA, and BRAF. Except for TP53 and PIK3CA, all other alterations were mutually exclusive. Genetic ancestry analysis revealed a predominance of European (71.1%), and a higher African ancestry was associated with TP53 mutations. Brazilian LCINS exhibited a similar molecular profile to other populations, except the increased ALK and TP53 alterations. Importantly, 73% of these patients have actionable alterations that are suitable for targeted treatments.
- Open Access
- 5 June 2024
- Published by Elsevier in Translational Oncology
- Vol. 46, 102003
Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer
- 5 June 2024
- Published by Elsevier in Translational Oncology
- Vol. 46, 102003
Open AccessImmune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer
- 15 June 2023
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 136 (1) , e20-e21
ADENOID CYSTIC CARCINOMA WITH BONE AND PLEURAL METASTASIS: A CASE REPORT
- 15 June 2023
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 136 (1) , e20-e21
ADENOID CYSTIC CARCINOMA WITH BONE AND PLEURAL METASTASIS: A CASE REPORT
- 15 June 2023
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 136 (1) , e20
NUT-CARCINOMA INVOLVING TRIGEMINAL NERVE - A CASE REPORT
- 15 June 2023
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 136 (1) , e20
NUT-CARCINOMA INVOLVING TRIGEMINAL NERVE - A CASE REPORT
- Open Access
- 1 June 2023
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 56 (3) , 157-161
Nova classificação das neoplasias gliais segundo a Organização Mundial da Saúde 2021, com enfoque radiológico
Resumo O propósito deste ensaio iconográfico é descrever e discutir as novas recomendações da Organização Mundial da Saúde de 2021, referente aos gliomas dos tipos adulto e infantil, e suas principais diferenças com a classificação anterior (2016), exemplificadas com imagens de nove casos de pacientes atendidos nas nossas instituições. Recentemente, há uma crescente significância dos marcadores moleculares no diagnóstico e classificação dos gliomas e tumores do sistema nervoso central, principalmente pela correlação com o comportamento biológico e o prognóstico. É importante que os neurorradiologistas estejam familiarizados com a nova classificação dos tumores do sistema nervoso central para a prática clínica, na avaliação e emissão de laudos e opiniões nas imagens dos pacientes com gliomas.
- 1 June 2023
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 56 (3) , 157-161
Open AccessNova classificação das neoplasias gliais segundo a Organização Mundial da Saúde 2021, com enfoque radiológico
Resumo O propósito deste ensaio iconográfico é descrever e discutir as novas recomendações da Organização Mundial da Saúde de 2021, referente aos gliomas dos tipos adulto e infantil, e suas principais diferenças com a classificação anterior (2016), exemplificadas com imagens de nove casos de pacientes atendidos nas nossas instituições. Recentemente, há uma crescente significância dos marcadores moleculares no diagnóstico e classificação dos gliomas e tumores do sistema nervoso central, principalmente pela correlação com o comportamento biológico e o prognóstico. É importante que os neurorradiologistas estejam familiarizados com a nova classificação dos tumores do sistema nervoso central para a prática clínica, na avaliação e emissão de laudos e opiniões nas imagens dos pacientes com gliomas.
- Open Access
- 1 June 2023
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 56 (3) , 157-161
The 2021 World Health Organization classification of gliomas: an imaging approach
The purpose of this pictorial essay is to describe the recommendations of the 2021 World Health Organization classification for adult-type and pediatric-type gliomas and to discuss the main modifications in relation to the previous (2016) classification, exemplified by imaging, histological, and molecular findings in nine patients followed at our institutions. In recent years, molecular biomarkers have gained importance in the diagnosis and classification of gliomas, mainly because they have been shown to correlate with the biological behavior and prognosis of such tumors. It is important for neuroradiologists to familiarize themselves with this new classification of central nervous system tumors, so that they can use this knowledge in evaluating and reporting the imaging examinations of patients with glioma.
- 1 June 2023
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 56 (3) , 157-161
Open AccessThe 2021 World Health Organization classification of gliomas: an imaging approach
The purpose of this pictorial essay is to describe the recommendations of the 2021 World Health Organization classification for adult-type and pediatric-type gliomas and to discuss the main modifications in relation to the previous (2016) classification, exemplified by imaging, histological, and molecular findings in nine patients followed at our institutions. In recent years, molecular biomarkers have gained importance in the diagnosis and classification of gliomas, mainly because they have been shown to correlate with the biological behavior and prognosis of such tumors. It is important for neuroradiologists to familiarize themselves with this new classification of central nervous system tumors, so that they can use this knowledge in evaluating and reporting the imaging examinations of patients with glioma.
- Open Access
- 1 February 2023
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Molecular Case Studies
- Vol. 9 (1) , a006245
Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing
Choroid plexus tumors (CPTs) are rare intracranial neoplasms, representing TP53germline mutations in the context of Li–Fraumeni syndrome, their somatic driver alterations remain poorly understood. In this study, we report two cases of lateral ventricle tumors: 3-yr-old male diagnosed with an atypical choroid plexus papilloma (aCPP), and a 6-mo-old female diagnosed with a choroid plexus carcinoma (CPC). We performed whole-exome sequencing of paired blood and tumor tissue in both patients, categorized somatic variants, and determined copy-number alterations. Our analysis revealed a tier II variant (Association for Molecular Pathology [AMP] criteria) inBRD1,aH3andTP53acetylation agent, in the aCPP. In addition, we detected copy-number gains on Chromosomes 12, 18, and 20 and copy-number losses on Chromosomes 13q and 22q (BRD1locus) in this tumor. The CPC tumor had only a pathogenic germlineTP53variant, based on American College of Medical Genetics (ACMG) criteria, with a clinical and familiar history of Li–Fraumeni syndrome. The CPC patient presented loss of heterozygosity (LoH) ofTP53loci and hyperdiploid genome. Both tumors were microsatellite-stable. This is the first study performing whole-exome sequencing in Brazilian choroid plexus tumors, and in line with the literature, we corroborate the absence of recurrent somatic mutations in these tumors. Further studies with larger sample sizes are necessary to confirm our findings and better understand the underlying biology of these tumors.
- 1 February 2023
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Molecular Case Studies
- Vol. 9 (1) , a006245
Open AccessGenomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing
Choroid plexus tumors (CPTs) are rare intracranial neoplasms, representing TP53germline mutations in the context of Li–Fraumeni syndrome, their somatic driver alterations remain poorly understood. In this study, we report two cases of lateral ventricle tumors: 3-yr-old male diagnosed with an atypical choroid plexus papilloma (aCPP), and a 6-mo-old female diagnosed with a choroid plexus carcinoma (CPC). We performed whole-exome sequencing of paired blood and tumor tissue in both patients, categorized somatic variants, and determined copy-number alterations. Our analysis revealed a tier II variant (Association for Molecular Pathology [AMP] criteria) inBRD1,aH3andTP53acetylation agent, in the aCPP. In addition, we detected copy-number gains on Chromosomes 12, 18, and 20 and copy-number losses on Chromosomes 13q and 22q (BRD1locus) in this tumor. The CPC tumor had only a pathogenic germlineTP53variant, based on American College of Medical Genetics (ACMG) criteria, with a clinical and familiar history of Li–Fraumeni syndrome. The CPC patient presented loss of heterozygosity (LoH) ofTP53loci and hyperdiploid genome. Both tumors were microsatellite-stable. This is the first study performing whole-exome sequencing in Brazilian choroid plexus tumors, and in line with the literature, we corroborate the absence of recurrent somatic mutations in these tumors. Further studies with larger sample sizes are necessary to confirm our findings and better understand the underlying biology of these tumors.